Skip to main content

Advertisement

Log in

Polypharmacy and potentially inappropriate medications in stroke rehabilitation: prevalence and association with outcomes

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Evidence is scarce regarding polypharmacy and potentially inappropriate medications (PIMs) in rehabilitation medicine. Aim To investigate the prevalence of polypharmacy and PIMs and their association with outcomes in stroke rehabilitation. Method A retrospective cohort study was conducted with 849 older inpatients post-stroke. Polypharmacy was defined as six or more medications, and PIMs were defined based on Beers criteria 2019. Study outcomes included functional independence measure (FIM)-motor, FIM-cognitive, energy intake, dysphagia, length of hospital stay, and the rate of home discharge. To consider the effect of pharmacotherapy during rehabilitation, multivariate analyses were used to determine whether the presence of polypharmacy or PIMs at discharge was associated with outcomes. Results After enrollment, 361 patients (mean age 78.3 ± 7.7 years; 49.3% male) were analyzed. Polypharmacy was observed in 43.8% and 62.9% of patients, and any PIMs were observed in 64.8% and 65.4% of patients at admission and discharge, respectively. The most frequently prescribed PIMs included antipsychotics, benzodiazepines, and proton pump inhibitors. Polypharmacy was negatively associated with FIM-motor score (β = − 0.062, P = 0.049), FIM-cognitive score (β = − 0.076, P = 0.014), energy intake (β = − 0.143, P = 0.005), and home discharge (OR: 0.458; 95% CI: 0.248, 0.847; P = 0.013). PIMs were negatively associated with home discharge (OR: 0.375; 95% CI: 0.195, 0.718; P = 0.003). Conclusion Polypharmacy and PIMs are commonly found among older patients undergoing stroke rehabilitation. Moreover, polypharmacy was negatively associated with activities of daily living (ADL) but not with PIMs and ADLs, and both were associated with home discharge.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Novaes PH, da Cruz DT, Lucchetti ALG, et al. The “iatrogenic triad”: polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults. Int J Clin Pharm. 2017;39:818–25.

    Article  CAS  PubMed  Google Scholar 

  2. Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, et al. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract. 2012;62:e821–6.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother. 2007;5:31–9.

    Article  PubMed  Google Scholar 

  4. Suzuki T, Iwagami M, Hamada S, et al. Number of consulting medical institutions and risk of polypharmacy in community-dwelling older people under a healthcare system with free access: a cross-sectional study in Japan. BMC Health Serv Res. 2020;20:1–9.

    Article  Google Scholar 

  5. Kalisch LM, Caughey GE, Roughead EE, Gilbert AL, et al. The prescribing cascade. Austral Prescriber. 2011;34:162–6.

    Article  Google Scholar 

  6. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003;38:843–53.

    Article  CAS  PubMed  Google Scholar 

  7. Doan J, Zakrzewski-Jakubiak H, Roy J, et al. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother. 2013;47:324–32.

    Article  PubMed  CAS  Google Scholar 

  8. Pasina L, Brucato AL, Falcone C, et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014;31:283–9.

    Article  CAS  PubMed  Google Scholar 

  9. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57–65.

    Article  PubMed  Google Scholar 

  10. Kojima T, Akishita M, Nakamura T, et al. Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int. 2012;12:425–30.

    Article  PubMed  Google Scholar 

  11. Martin NJ, Stones MJ, Young JE, et al. Development of delirium: a prospective cohort study in a community hospital. Int Psychogeriatr. 2000;12:117–27.

    Article  CAS  PubMed  Google Scholar 

  12. Fried TR, O’Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62:2261–72.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Fick DM, Semla TP, Steinman M, et al. American geriatrics society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–94.

    Article  Google Scholar 

  14. Glass J, Lanctôt KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Manias E, Kabir MZ, Maier AB. Inappropriate medications and physical function: a systematic review. Ther Adv Drug Saf. 2021;12:20420986211030372.

    Article  Google Scholar 

  16. Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health. 2008;31:42–51.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Jensen LD, Andersen O, Hallin M, et al. Potentially inappropriate medication related to weakness in older acute medical patients. Int J Clin Pharm. 2014;36:570–80.

    Article  PubMed  Google Scholar 

  18. Wakabayashi H. Rehabilitation pharmacotherapy: a combination of rehabilitation and pharmacotherapy. J Gen Fam Med. 2018;19:43–4.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kose E, Toyoshima M, Okazoe S, et al. The relationship between polypharmacy and recovery of activities of daily living among convalescent stroke patients: a propensity score-matched analysis. Eur Geriatr Med. 2017;8:250–5.

    Article  Google Scholar 

  20. Kose E, Hirai T, Seki T. Clinical factors affecting potentially inappropriate medications at discharge in older stroke patients. Eur Geriatr Med. 2018;9:161–8.

    Article  PubMed  Google Scholar 

  21. Kose E, Wakabayashi H. Rehabilitation pharmacotherapy a scoping review. Geriatrics and Gerontology International. Hoboken: Blackwell Publishing; 2020. p. 655–63.

    Google Scholar 

  22. Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is sufficient to predict stroke outcome–reintroduction of Japan Coma Scale: a cohort study. BMJ Open. 2013;3: e002736.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rubenstein LZ, Harker JO, Salvà A, et al. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci. 2001;56:M366–72.

    Article  CAS  PubMed  Google Scholar 

  24. Kunieda K, Ohno T, Fujishima I, et al. Reliability and validity of a tool to measure the severity of dysphagia: the Food Intake LEVEL Scale. J Pain Symptom Manag. 2013;46:201–6.

    Article  Google Scholar 

  25. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    Article  CAS  PubMed  Google Scholar 

  26. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38:1091–6.

    Article  PubMed  Google Scholar 

  27. Ottenbacher KJ, Hsu Y, Granger CV, et al. The reliability of the functional independence measure: a quantitative review. Arch Phys Med Rehabil. 1996;77(12):1226–32.

    Article  CAS  PubMed  Google Scholar 

  28. Kaido T, Uemoto S. Direct segmental multi-frequency bioelectrical impedance analysis is useful to evaluate sarcopenia. Am J Transplant. 2013;13:2506–7.

    Article  CAS  PubMed  Google Scholar 

  29. Chen L-K, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-307.e2.

    Article  PubMed  Google Scholar 

  30. Salinas-Rodríguez A, Manrique-Espinoza B, Rivera-Almaraz A, et al. Polypharmacy is associated with multiple health-related outcomes in Mexican community-dwelling older adults. Salud Publica Mex. 2020;62:246–54.

    Article  PubMed  Google Scholar 

  31. Yuki A, Otsuka R, Tange C, et al. Polypharmacy is associated with frailty in Japanese community-dwelling older adults. Geriatr Gerontol Int. 2018;18:1497–500.

    Article  PubMed  Google Scholar 

  32. Bushardt RL, Massey EB, Simpson TW, et al. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3:383–9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Kojima T, Akishita M, Kameyama Y, et al. High risk of adverse drug reactions in elderly patients taking six or more drugs: analysis of inpatient database. Geriatr Gerontol Int. 2012;12:761–2.

    Article  PubMed  Google Scholar 

  34. Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1–10.

    Article  Google Scholar 

  35. Sawaya AL, Tucker K, Tsay R, et al. Evaluation of four methods for determining energy intake in young and older women: comparison with doubly labeled water measurements of total energy expenditure. Am J Clin Nutr. 1996;63:491–9.

    Article  CAS  PubMed  Google Scholar 

  36. Kus S, Müller M, Strobl R, et al. Patient goals in post-acute geriatric rehabilitation–goal attainment is an indicator for improved functioning. J Rehabil Med. 2011;43:156–61.

    Article  PubMed  Google Scholar 

  37. Kido Y, Yoshimura Y, Wakabayashi H, et al. Sarcopenia is associated with incontinence and recovery of independence in urination and defecation in post-acute rehabilitation patients. Nutrition. 2021;91–92: 111397.

    Article  PubMed  Google Scholar 

  38. Beninato M, Gill-Body KM, Salles S, et al. Determination of the minimal clinically important difference in the FIM instrument in patients with stroke. Arch Phys Med Rehabil. 2006;87:32–9.

    Article  PubMed  Google Scholar 

  39. Nishioka S, Aragane H, Suzuki N, et al. Clinical practice guidelines for rehabilitation nutrition in cerebrovascular disease, hip fracture, cancer, and acute illness: 2020 update. Clin Nutr ESPEN. 2021;43:90–103.

    Article  PubMed  Google Scholar 

  40. Oyanagi K, Kitai T, Yoshimura Y, et al. Effect of early intensive rehabilitation on the clinical outcomes of patients with acute stroke. Geriatr Gerontol Int. 2021;21:623–8.

    Article  PubMed  Google Scholar 

  41. Yoshimura Y, Wakabayashi H, Momosaki R, et al. Shorter interval between onset and admission to convalescent rehabilitation wards is associated with improved outcomes in ischemic stroke patients. Tohoku J Exp Med. 2020;252:15–22.

    Article  PubMed  Google Scholar 

  42. Yoshimura Y, Bise T, Nagano F, et al. Systemic inflammation in the recovery stage of stroke: its association with sarcopenia and poor functional rehabilitation outcomes. Prog Rehabil Med. 2018;3:20180011.

    PubMed  PubMed Central  Google Scholar 

  43. Shimazu S, Yoshimura Y, Kudo M, et al. Frequent and personalized nutritional support leads to improved nutritional status, activities of daily living, and dysphagia after stroke. Nutrition. 2021;83:111091.

    Article  CAS  PubMed  Google Scholar 

  44. Ye Z, Reintam Blaser A, Lytvyn L, et al. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020;368:l6722.

  45. Kamada T, Satoh K, Itoh T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2020. J Gastroenterol. 2021;56:303–22.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:E344-418.

    Article  PubMed  Google Scholar 

  47. Kose E, Hirai T, Seki T, et al. The association of increased drugs use with activities of daily living and discharge outcome among elderly stroke patients. Int J Clin Pharm. 2018;40:599–607.

    Article  PubMed  Google Scholar 

  48. Heuberger RA, Caudell K. Polypharmacy and nutritional status in older adults. Drugs Aging. 2011;28:315–23.

    Article  PubMed  Google Scholar 

  49. Wolf U, Eckert S, Walter G, et al. Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs. Sci Rep. 2021;11:1–14.

    Article  CAS  Google Scholar 

  50. Kose E, Hirai T, Seki T, et al. Role of potentially inappropriate medication use in rehabilitation outcomes for geriatric patients after strokes. Geriatr Gerontol Int. 2018;18:321–8.

    Article  PubMed  Google Scholar 

  51. Vluggen TPMM, van Haastregt JCM, Tan FES, et al. Factors associated with successful home discharge after inpatient rehabilitation in frail older stroke patients. BMC geriatr. 2020;20:25.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Chang F-H, Ni P, Jette AM. Does activity limitation predict discharge destination for postacute care patients? Am J Phys Med Rehabil. 2014;93:782–90.

    Article  PubMed  Google Scholar 

  53. Everink IHJ, van Haastregt JCM, van Hoof SJM, et al. Factors influencing home discharge after inpatient rehabilitation of older patients: a systematic review. BMC Geriatr. 2016;16:5.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Yoshimura Y, Wakabayashi H, Bise T, et al. Sarcopenia is associated with worse recovery of physical function and dysphagia and a lower rate of home discharge in Japanese hospitalized adults undergoing convalescent rehabilitation. Nutrition. 2019;61:111–8.

    Article  PubMed  Google Scholar 

  55. Kose E, Hirai T, Seki T. Psychotropic drug use and cognitive rehabilitation practice for elderly patients. Int J Clin Pharm. 2018;40:1292–9.

    Article  CAS  PubMed  Google Scholar 

  56. Gamble J-M, Hall JJ, Marrie TJ, et al. Medication transitions and polypharmacy in older adults following acute care. Ther Clin Risk Manag. 2014;10:189–96.

    PubMed  PubMed Central  Google Scholar 

  57. Mixon AS, Neal E, Bell S, et al. Care transitions: a leverage point for safe and effective medication use in older adults–a mini-review. Gerontology. 2015;61:32–40.

    Article  PubMed  Google Scholar 

  58. Clarke CL, Witham MD. The effects of medication on activity and rehabilitation of older people—opportunities and risks. Rehabil Process Outcome. 2017;6:1179572717711433.

    Article  Google Scholar 

  59. Willoch K, Blix HS, Pedersen-Bjergaard AM, et al. Handling drug-related problems in rehabilitation patients: a randomized study. Int J Clin Pharm. 2012;34:382–8.

    Article  PubMed  Google Scholar 

  60. O’mahony D, O’sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to express our deepest gratitude to the Nutrition Support Team of Kumamoto Rehabilitation Hospital for their support of this study.

Funding

This research did not receive any funding from agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihiro Yoshimura.

Ethics declarations

Conflicts of interest

The authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 24 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsumoto, A., Yoshimura, Y., Nagano, F. et al. Polypharmacy and potentially inappropriate medications in stroke rehabilitation: prevalence and association with outcomes. Int J Clin Pharm 44, 749–761 (2022). https://doi.org/10.1007/s11096-022-01416-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-022-01416-5

Keywords

Navigation